简介：Nature Reviews Cardiology provides physicians and academics with authoritative and topical discussions of key developments in the field.

原站：http://www.nature.com/ncpcardio/current_issue/

指数：

“Nature Reviews Cardiology - Issue - nature.com scien”的内容更新

累计：730 篇（自 2007-05-21 起）

更新：约3篇/周，最后更新18 天前

Nature Reviews Cardiology - Issue - nature.com science feeds

Interventional cardiology: Examining the issues rela

interventional cardiology: examining the issues related to pci without on-site surgical back-upnature reviews cardiology 9, 65 (2012). doi:10.1038/nrcardio.2011.209author: alexandra kinga meta-analysis conducted by a team of researchers from the usa has provided new evidence that could lend support to the use of percutaneous coronary interventio... (18 天前)

http://inezha.com/w/gh9snmx0

Nature Reviews Cardiology - Issue - nature.com science feeds

Acute coronary syndromes: Rivaroxaban reduces seriou

acute coronary syndromes: rivaroxaban reduces serious cv events without increasing fatal bleeding in patients with a recent acsnature reviews cardiology 9, 1 (2012). doi:10.1038/nrcardio.2011.181author: bryony m. mearnsresults of the atlas acs 2–timi 51 trial were released at the 2011 aha scientific sessions in orlando, fl, and published in the... (64 天前)

http://inezha.com/w/ufxa8mxl

Nature Reviews Cardiology - Issue - nature.com science feeds

Atherosclerosis: Coronary effects of intensive stati

atherosclerosis: coronary effects of intensive statinsnature reviews cardiology 9, 2 (2012). doi:10.1038/nrcardio.2011.182author: bryony m. mearnsin mid november, stephen nicholls et al. presented the findings of the saturn study at the 2011 aha scientific sessions, and simultaneously published them in the new england journal of medicine. maxima... (64 天前)

http://inezha.com/w/z7egtzxi

Nature Reviews Cardiology - Issue - nature.com science feeds

Acute coronary syndromes: Thrombin-receptor antagoni

acute coronary syndromes: thrombin-receptor antagonist increases bleeding in patients with acsnature reviews cardiology 9, 2 (2012). doi:10.1038/nrcardio.2011.183author: gregory b. limvorapaxar, a first-in-class, oral antagonist of protease-activated receptor 1 (par-1), inhibits thrombin-induced platelet activation, but failed to reduce the prim... (64 天前)

http://inezha.com/w/qc9rhzxf

Nature Reviews Cardiology - Issue - nature.com science feeds

Device therapy: Public-access AEDs improve neurologi

device therapy: public-access aeds improve neurologically intact survival after cardiac arrestnature reviews cardiology 8, 667 (2011). doi:10.1038/nrcardio.2011.165author: gregory b. limon-site, public-access, automated external defibrillators (aeds) more than double the chance of neurologically intact survival after an out-of-hospital cardiac a... (84 天前)

http://inezha.com/w/2kx8czx9

Nature Reviews Cardiology - Issue - nature.com science feeds

Hypertension: First-in-class agent lowers BP

hypertension: first-in-class agent lowers bpnature reviews cardiology 8, 668 (2011). doi:10.1038/nrcardio.2011.163author: gregory b. lima novel inhibitor of aldosterone synthase, lci699, safely reduces serum aldosterone levels, as well as clinic and ambulatory blood pressure in patients with primary hypertension. “aldosterone, in combination wi... (84 天前)

http://inezha.com/w/8jewmzxu

Nature Reviews Cardiology - Issue - nature.com science feeds

Valvular disease: The UK TAVI experience: insights f

valvular disease: the uk tavi experience: insights from the 'real world'nature reviews cardiology 8, 668 (2011). doi:10.1038/nrcardio.2011.166author: alexandra kingthe first report from the united kingdom transcatheter aortic valve implantation (uk tavi) registry provides important new information on the mid-term and long-term outcomes of patien... (84 天前)

http://inezha.com/w/o9953zxt

订阅者 ( 3 )

相关订阅源